COMPUGEN LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2.5 USD | -0.79% |
|
+6.93% | +26.37% |
| 05-20 | Truist Securities Trims Price Target on Compugen to $4 From $5, Maintains Buy Rating | MT |
| 05-20 | Transcript : Compugen Ltd., Q1 2024 Earnings Call, May 20, 2024 |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Compared values
| Sector | Change | 5d. change | 1st Jan change | 1-year change | 5-years change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| COMPUGEN LTD. | Other Biotechnology & Medical Research | -0.71% | +6.93% | +26.37% | +136.06% | -19.54% | 226M |  | | |
Technical Rankings Surperformance
- Stock Market
- Equities
- CGEN Stock
- Charts Compugen Ltd.
- Comparison Chart
